M235T angiotensinogen gene polymorphism and cardiovascular renal risk

被引:154
作者
Staessen, JA
Kuznetsova, T
Wang, JG
Emelianov, D
Vlietinck, R
Fagard, R
机构
[1] Univ Leuven, Hypertens & Cardiovasc Rehabil Unit, Louvain, Belgium
[2] Univ Leuven, Ctr Human Genet, Louvain, Belgium
关键词
angiotensinogen; cardiomyopathy; coronary heart disease; genetic polymorphism; hypertension; myocardium; nephropathy; stroke;
D O I
10.1097/00004872-199917010-00003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective In this meta-analysis, we attempted to derive pooled estimates for the putative associations between various cardiovascular-renal disorders and the M235T polymorphism of the angiotensinogen gene. Methods Case-control studies were combined, using the Mantel and Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the intrastudy mean of the MM genotype as denominator. Results The computerized database used for this analysis included 69 reports with an overall sample size of 27 906 subjects. Overall, possession of the 7 allele was associated with an increased risk of hypertension. In comparison with the MM reference group (number of studies, n = 32), the excess risk was 31% (P = 0.001) in TT homozygotes and 11% (P = 0.03) in TM heterozygotes. The sensitivity analysis showed that this association was present only in whites (7 allelic frequency, f = 42.2%), but not in blacks (f = 77.0%) or Asians (f = 78.0%). Atherosclerotic complications (n = 12), renal microvascular disorders (n = 13), cardiomyopathy (n = 2) or diabetic retinopathy (n = 3) were not correlated with the M235T polymorphism. Publication bias was observed for hypertension, but not for coronary heart disease, including myocardial infarction, and for microvascular nephropathy. Furthermore, in comparison with the MM control group, the circulating angiotensinogen levels (n = 8) were raised by 11 and 7% (P = 0.01) in 77 and TM subjects, respectively. In contrast, plasma levels of the angiotensin I converting enzyme (n = 4) and body mass index (n = 15) were not associated with the T allele. Conclusion The T allele encoding angiotensinogen is not associated with atherosclerotic or microvascular complications, but in Caucasians behaves as a marker for hypertension. This association, which may have been inflated by publication bias, does not necessarily imply causality. J Hypertens 1999; 17:9-17 (C) Lippincott Williams & Wilkins.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 95 条
[1]  
[Anonymous], 1985, STAT METHODS METAANA
[2]  
BARLEY J, 1994, J HUM HYPERTENS, V8, P639
[3]  
BARLEY R, 1995, J HUM HYPERTENS, V9, P681
[4]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[5]   Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension [J].
Beige, J ;
Zilch, O ;
Hohenbleicher, H ;
Ringel, J ;
Kunz, R ;
Distler, A ;
Sharma, AM .
JOURNAL OF HYPERTENSION, 1997, 15 (05) :503-508
[6]  
Beige J, 1996, NEPHROL DIAL TRANSPL, V11, P1538
[7]   CROSS-SECTIONAL ANALYSIS OF MET(235)-]THR VARIANT OF ANGIOTENSINOGEN GENE IN SEVERE, FAMILIAL HYPERTENSION [J].
BENNETT, CL ;
SCHRADER, AP ;
MORRIS, BJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :833-839
[8]   No effect of genetic variation at the angiotensinogen locus on ambulatory blood pressure level in normotensive subjects [J].
Bigda, J ;
Narkiewicz, K ;
Chrostowska, M ;
Winnicki, M ;
Szczech, R ;
Pawlowski, R ;
KrupaWojciechowska, B .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (06) :692-695
[9]   Human renin-dependent hypertension in rats transgenic for human angiotensinogen [J].
Bohlender, J ;
Menard, J ;
Wagner, J ;
Luft, FC ;
Ganten, D .
HYPERTENSION, 1996, 27 (03) :535-540
[10]   Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study [J].
Borecki, IB ;
Province, MA ;
Ludwig, EH ;
Ellison, RC ;
Folsom, AR ;
Heiss, G ;
Lalouel, JM ;
Higgins, M ;
Rao, DC .
ANNALS OF EPIDEMIOLOGY, 1997, 7 (01) :13-21